TNDM - Tandem Diabetes Care, Inc

Healthcare - Sector

TNDM is currently covered by 13 analysts with average potential upside of $19.88 (26.2%) backed by 170 price targets and 179 ratings. Analyst's average stock valuation to be materialised ratio is 74.75% with an average time for price targets to be met of 99.53 days.

Most recent stock forecast was given by LAWRENCE BIEGELSEN from WELLS FARGO on 15-Nov-2022.

Highest price target for TNDM is 146, Lowest price target is 36, average price target is 91.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Sell

43

$0.95 (2.26%)

49

16 days ago

5/9 (55.56%)

$17.53 (17.81%)

67

Buy

52

$9.95 (23.66%)

90

27 days ago

6/9 (66.67%)

$12.85 (21.09%)

89

Buy

70

$27.95 (66.47%)

80

28 days ago

14/19 (73.68%)

$19.3 (24.20%)

136

Buy

75

$32.95 (78.36%)

160

1 months 19 days ago

1/3 (33.33%)

$25.4 (33.05%)

2

Buy

105

$62.95 (149.70%)

153

3 months 27 days ago

11/12 (91.67%)

$25.63 (37.52%)

182

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login